26 июня 2013, 17:04
Аналитика на 26 июня
Спайдер повышается перед открытием торгов на NYSE.
SPY (внутридневной график) рост на премаркете. Сопротивление: 159.50 Поддержка: 158.50
ПремаркетNYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: SYNA +14.4%, AVAV +5.7%, MON +2.1%.
M&A news:HOMB +3.4% (Home Bancshares and Liberty Bancshares announce business combination; shareholders of Liberty will receive $250 mln of Home common stock plus $30 mln in cash, also upgraded at Wunderlich and Raymond James).
Select EU pharma related names showing strength: SNY +2.9%, AZN +2%, NVS +0.7% (reported new Phase III data showing omalizumab significantly improves itch in patients with severe form of chronic skin disease).
Other news: NVMI +7.3% (announced that a leading edge memory manufacturer recently placed a significant order for multiple software licenses of its NovaMARS 3D modeling solution), PSTI +5.3% (enters into strategic partnership and licensing agreement with Cha Bio&Diostech for the development and commercialization of PLX Cells for the treatment of CLI and IC in South Korea), CRAY +3.9% (announced the European Centre for Medium-Range Weather Forecasts selected a Cray XC30 supercomputer and Cray Sonexion storage for their next operational facility), CLNT +3.7% (cont strength following Pres Obama clean energy speech), IGLD +2.9% (still checking), ATML +2.3% (in sympathy with SYNA), RPTP +1.6% (PROCYSBI received U.S. orphan drug exclusivity); TSLA +1.4% (reports of German article suggesting production and sale of 200K cars in next 3-4 yrs), .
Analyst comments: P +4.2% (upgraded to Outperform from Neutral at Cowen), ALLT +4% (upgraded to Buy at Wunderlich; upgraded to Outperform at Wedbush), MLNX +2.7% (upgraded to Buy at Stifel; tgt $63), SAN +2.5% (upgraded to Neutral from Sell at Citigroup), ADBE +2.3% (upgraded to Overweight to Buy at Jeffries), RAX +2.2% (upgraded to Outperform from Market Perform at Wells Fargo), MGM +2.1% (upgraded to Buy from Neutral at Nomura), KEY +2% (upgraded to Outperform from Market Perform at BMO Capital Markets), ARMH +1% (upgraded to Overweight from Neutral at Piper Jaffray. Upgraded to buy at The Benchmark Company).
Gapping down:
In reaction to disappointing earnings/guidance: MG -13.6%, FCFS -9.4%, BCC -5.3%, SNX -3.8%, APOL -3.3%.
Select metals/mining stocks trading lower: SSRI -6.8%, AU -6.6%, GFI -6.5%, EGO -6%, HL -5.6%, AG -5%, SLW -5%, SLV -4.7%, GLD -3.5%.
Other news: CIDM -7.2% (announces commencement of an underwritten public offering, size not disclosed), FIVE -6.2% (attributed to previously postponed pricing of offering), PTNR -3.3% (class action suit filed against co), ISRG -2.2% (following FDA inspection update), OMAB -1.9% (Empresas ICA and co announced that ICA has elected not to conclude and to postpone the registered public offering of OMA's Series B shares by Aeroinvest, ICA's subsidiary, because of market conditions), ODP -1.8% (Delaware Court confirms annual shareholder meeting date of August 21, 2013).
Analyst comments: ABX -4.5% (downgraded to Neutral from Outperform at Credit Suisse), PAAS -4.5% (downgraded to Neutral from Outperform at Credit Suisse).
Торговые идеи NYSEи NASDAQ:
SYNA– шорт ниже 40.50, либо от максимума премаркета 41.50
P– лонг выше максимума премаркета.
MLNX– лонг при закреплении выше 50.00
APOL – лонг выше 18.50
Оригинал статьи: http://shark-traders.com/blog/analitika-na-26-iyunya/
- Европейские индексы на положительной территории.
SPY (внутридневной график) рост на премаркете. Сопротивление: 159.50 Поддержка: 158.50
ПремаркетNYSE/NASDAQ:
Gapping up:
In reaction to strong earnings/guidance: SYNA +14.4%, AVAV +5.7%, MON +2.1%.
M&A news:HOMB +3.4% (Home Bancshares and Liberty Bancshares announce business combination; shareholders of Liberty will receive $250 mln of Home common stock plus $30 mln in cash, also upgraded at Wunderlich and Raymond James).
Select EU pharma related names showing strength: SNY +2.9%, AZN +2%, NVS +0.7% (reported new Phase III data showing omalizumab significantly improves itch in patients with severe form of chronic skin disease).
Other news: NVMI +7.3% (announced that a leading edge memory manufacturer recently placed a significant order for multiple software licenses of its NovaMARS 3D modeling solution), PSTI +5.3% (enters into strategic partnership and licensing agreement with Cha Bio&Diostech for the development and commercialization of PLX Cells for the treatment of CLI and IC in South Korea), CRAY +3.9% (announced the European Centre for Medium-Range Weather Forecasts selected a Cray XC30 supercomputer and Cray Sonexion storage for their next operational facility), CLNT +3.7% (cont strength following Pres Obama clean energy speech), IGLD +2.9% (still checking), ATML +2.3% (in sympathy with SYNA), RPTP +1.6% (PROCYSBI received U.S. orphan drug exclusivity); TSLA +1.4% (reports of German article suggesting production and sale of 200K cars in next 3-4 yrs), .
Analyst comments: P +4.2% (upgraded to Outperform from Neutral at Cowen), ALLT +4% (upgraded to Buy at Wunderlich; upgraded to Outperform at Wedbush), MLNX +2.7% (upgraded to Buy at Stifel; tgt $63), SAN +2.5% (upgraded to Neutral from Sell at Citigroup), ADBE +2.3% (upgraded to Overweight to Buy at Jeffries), RAX +2.2% (upgraded to Outperform from Market Perform at Wells Fargo), MGM +2.1% (upgraded to Buy from Neutral at Nomura), KEY +2% (upgraded to Outperform from Market Perform at BMO Capital Markets), ARMH +1% (upgraded to Overweight from Neutral at Piper Jaffray. Upgraded to buy at The Benchmark Company).
Gapping down:
In reaction to disappointing earnings/guidance: MG -13.6%, FCFS -9.4%, BCC -5.3%, SNX -3.8%, APOL -3.3%.
Select metals/mining stocks trading lower: SSRI -6.8%, AU -6.6%, GFI -6.5%, EGO -6%, HL -5.6%, AG -5%, SLW -5%, SLV -4.7%, GLD -3.5%.
Other news: CIDM -7.2% (announces commencement of an underwritten public offering, size not disclosed), FIVE -6.2% (attributed to previously postponed pricing of offering), PTNR -3.3% (class action suit filed against co), ISRG -2.2% (following FDA inspection update), OMAB -1.9% (Empresas ICA and co announced that ICA has elected not to conclude and to postpone the registered public offering of OMA's Series B shares by Aeroinvest, ICA's subsidiary, because of market conditions), ODP -1.8% (Delaware Court confirms annual shareholder meeting date of August 21, 2013).
Analyst comments: ABX -4.5% (downgraded to Neutral from Outperform at Credit Suisse), PAAS -4.5% (downgraded to Neutral from Outperform at Credit Suisse).
Торговые идеи NYSEи NASDAQ:
SYNA– шорт ниже 40.50, либо от максимума премаркета 41.50
P– лонг выше максимума премаркета.
MLNX– лонг при закреплении выше 50.00
APOL – лонг выше 18.50
Оригинал статьи: http://shark-traders.com/blog/analitika-na-26-iyunya/
0 Комментариев
11:28
поглядел 20 минут в стакан сишки и глаз начал дергаться.
Газпром стал владельцем 50% в Балтийском химическом комплексе Новые владельцы БХКИз данных ЕГРЮЛ следует, что РусГазДобыча, ранее являвшаяся основным акционером БХК, вышла из проекта.
По данным ЕГРЮ...
Дмитрий Клопов, только лонг по любой цене
11:25
⚡ Big Swinging Dick, стабильно)))
Но сейчас же доходность по облигациям за 50% переваливает
Виталий, тоже хочу посмотреть реакцию на включение в индекс
Bio, По 4300 же покупали
Fesco открыла дочернюю компанию во Вьетнаме Компания, получившая название DBF Logistics Vietnam, имеет два полноценных офиса во вьетнамских городах Хошимин, Хайфон, а также коммерческое представительс...
Китай в октябрьское межсезонье уменьшил импорт СПГ и нарастил импорт по трубе Суммарный импорт природного газа (по трубе и через СПГ) в октябре 2024 составил 14,038 млрд куб. м, что почти равно (-1%) ...
Не исковые, а погашение долга, миром